Quantum Computing in Healthcare Market by Component (Hardware, Software), Deployment (On-premises, Cloud-based), Technology (Superconducting Qubits, Trapped Ions), Application (Drug Discovery, Genomics), End User, and Region - Global Forecast to 2030

The global quantum computing in healthcare market is projected to reach USD 1,324.2 million by 2030 from USD 265.9 million in 2025 at a high CAGR of 37.9% during the forecast period. The quantum computing market in healthcare is steadily advancing due to the pressing need to improve drug discovery, enhance clinical decision-making, and increase diagnostic accuracy. As healthcare data becomes more complex and voluminous, quantum computing offers powerful tools for simulation, modeling, and advanced data processing that surpass traditional systems. These solutions are expected to significantly reduce research timelines and costs while also facilitating the development of more targeted and personalized treatments.

The growth of this market is further supported by increasing funding for quantum startups, government-backed research initiatives, and collaborative efforts between academia and industry. However, the sector faces challenges, particularly regarding the accuracy of quantum systems and the high costs associated with their implementation, which continue to hinder widespread adoption.

“The superconducting qubits segment is expected to be the largest segment during the forecast period.”

In 2024, superconducting qubits emerged as the largest segment in the quantum computing market for healthcare and are expected to maintain this position in the coming years. This dominance is driven by their maturity, scalability potential, and strong performance in executing complex computational tasks.

Superconducting qubit systems offer high-speed processing capabilities, making them well-suited for healthcare applications such as molecular simulations, genomic analysis, and drug discovery. These systems are also compatible with cloud-based quantum platforms, allowing researchers and clinicians broader access without the need for extensive on-premises infrastructure.

As the demand for more efficient tools to handle biomedical data and accurately model biological systems grows, superconducting qubit technology is increasingly being adopted in healthcare-focused quantum initiatives. Continued advancements in coherence times, error correction, and integration with hybrid computing frameworks further reinforce their role as a foundational technology for accelerating innovation in healthcare.

“Healthcare payers are expected to be the fastest-growing segment in the quantum computing in healthcare market, by end user, during the forecast period.”

Healthcare payers have emerged as the fastest-growing end-user group in the quantum computing in healthcare market. This trend is driven by the increasing need for advanced data processing tools to manage healthcare costs, assess patient risks, and support personalized coverage plans. Quantum computing enables quicker analysis of complex datasets, allowing payers to enhance risk prediction, detect anomalies, and develop value-based reimbursement models. As the healthcare industry shifts toward data-driven decision-making, payers are adopting quantum technologies to improve operational efficiency, reduce fraud, and gain deeper insights into treatment outcomes and population health.

“Asia Pacific is expected to witness the highest growth rate during the forecast period.”

The Asia Pacific region is projected to experience the fastest growth in the quantum computing in healthcare market during the forecast period. This growth is driven by increasing government support for quantum technology, a rise in research collaborations, and a surge in funding for emerging tech startups. Countries in the region are prioritizing quantum innovation through national strategies and investments, establishing a strong foundation for the application of these technologies in healthcare.

As the burden of chronic diseases grows, there is an increased focus on utilizing quantum computing for tasks such as drug research, genetic analysis, and complex data modeling. Additionally, enhanced digital infrastructure and wider access to cloud-based quantum platforms are facilitating faster adoption. Collectively, these factors are positioning Asia Pacific as a key hub for advancements in quantum healthcare.

The breakdown of primary participants is as mentioned below:

• By Company Type: Tier 1 (45%), Tier 2 (30%), and Tier 3 (25%)
• By Designation: Directors (42%), Managers (31%), and Others (27%)
• By Region: North America (32%), Europe (26%), Asia Pacific (32%), the Middle East & Africa (5%), and Latin America (5%)

Key Players in the Quantum Computing in Healthcare Market

The key players operating in the quantum computing in healthcare market include Rigetti & Co, LLC (US), IBM (US), D-Wave Quantum Inc. (Canada), Microsoft (US), IonQ (US), Quantinuum, Ltd. (US & UK), Google, Inc. (US), Atos SE (France), QC Ware (California), Classiq Technologies, Inc. (US), Xanadu Quantum Technologies Inc. (Canada), Hefei Origin Quantum Computing Technology Co., Ltd. (China), Protiviti, Inc. (US), Quandela (France), Deloitte (UK), Accenture (Ireland), Amazon Web Services (AWS) (US), Fujitsu (Japan), Qnami (Switzerland), SEEQC (US), SandboxAQ (US), Pasqal (France), Qubit Pharmaceuticals (France), Polaris Quantum Biotech (US), and QSimulate (US).

Research Coverage

The report analyzes the quantum computing in healthcare market and estimates the market size and future growth potential of various market segments based on component, deployment, application, technology, end user, and region. It also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

• Analysis of key drivers (increasing investments in quantum computing in developed as well as emerging economies, growing inclination of payers toward quantum computing, rising demand for personalized medicine, increasing funding and investments in quantum computing startups, and rising need to reduce time and cost of drug discovery and development), restraints (accuracy issues with quantum computing systems and high implementation costs), opportunities (technological advancements in quantum computing supporting various healthcare applications and potential applications in medical image analysis and oncology), and challenges (lack of technical expertise & data management issues) influencing the growth of the quantum computing in healthcare market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the quantum computing in healthcare market.
• Market Development: Comprehensive information on the lucrative emerging markets. The report analyzes the market for various types of quantum computing in healthcare solutions across regions.
• Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the quantum computing in healthcare market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the quantum computing in healthcare market, like Rigetti & Co, LLC (US), IBM (US), D-Wave Quantum Inc. (Canada), Microsoft (US), and IonQ (US).